Chapter 13: Cost-Effectiveness Analysis, Cost-Utility Analysis, and Cost-Benefit Analysis

2017 ◽  
Author(s):  
Junhua Yu ◽  
Jaewhan Kim
Keyword(s):  
Cost Effectiveness ◽  
Cost Benefit Analysis ◽  
Cost Benefit ◽  
Cost Utility ◽  
Cost Effectiveness Analysis ◽  
Cost Utility Analysis ◽  
Benefit Analysis ◽  
Utility Analysis ◽  
Effectiveness Analysis

scholarly journals The study of Pharmacoeconomics analysis on anti tuberculosis drugs Rifampicin & Ethambutol

2018 ◽  
Vol 1 (1) ◽  
pp. 31-40
Author(s):  
Arsalan Sarmad ◽  
B. Syed Salman ◽  
Syed Sharfuddin Ibrahim
Keyword(s):  
Cost Effectiveness ◽  
Cost Benefit Analysis ◽  
Cost Minimization ◽  
Cost Benefit ◽  
Minimum Cost ◽  
Cost Utility ◽  
Cost Utility Analysis ◽  
Effective Therapy ◽  
Benefit Analysis ◽  
Utility Analysis

Cost-benefit analysis can be used to quantify the value of clinical pharmacy services. Providing Effective Therapy and Minimum cost, Quantify costs of care, Quantify outcomes, Assess whether and by how much average costs and outcomes differ among treatment groups, Compare magnitude of difference in costs and outcomes and evaluate “value for costs” by reporting a cost-effectiveness ratio, net monetary benefit, or probability that ratio is acceptable – Potential hypothesis: Cost per quality-adjusted life year saved significantly less than Rs.75,000, To Perform sensitivity analysis. For providing good effective therapy with less adverse drug reaction at affordable price, Cost-Identification, Cost-Effectiveness Analysis, Cost-Utility Analysis, Cost-Benefit Analysis, Clinical outcomes: Cure, comfort and survival, Humanistic outcomes: Physical, emotional, social function, role performance, Economic outcomes, Economic Evaluation, Cost of Illness Evaluation (COI), Cost Benefit Analysis (CBA), Cost Minimization Analysis, Cost Effective Analysis: Cost Utility Analysis.

Application of Cost-Benefit Analysis to the Health Services and the Special Case of Technologic Innovation

1974 ◽  
Vol 4 (2) ◽  
pp. 325-352 ◽  
Author(s):  
Herbert E. Klarman
Keyword(s):  
Cost Effectiveness ◽  
Public Sector ◽  
Health Services ◽  
Cost Benefit Analysis ◽  
Cost Benefit ◽  
Cost Effectiveness Analysis ◽  
Benefit Analysis ◽  
Costs And Benefits ◽  
The Public ◽  
Effectiveness Analysis

As an economic technique for evaluating specific projects or programs in the public sector, cost-benefit analysis is relatively new. In this paper, the theory and practice of cost-benefit analysis in general are discussed as a basis for considering its role in assessing technology in the health services. A review of the literature on applications of cost-benefit or cost-effectiveness analysis to the health field reveals that few complete studies have been conducted to date. It is suggested that an adequate analysis requires an empirical approach in which costs and benefits are juxtaposed, and in which presumed benefits reflect an ascertained relationship between inputs and outputs. A threefold classification of benefits is commonly employed: direct, indirect, and intangible. Since the latter pose difficulty, cost-effectiveness analysis is often the more practicable procedure. After summarizing some problems in predicting how technologic developments are likely to affect costs and benefits, the method of cost-benefit analysis is applied to developments of health systems technology in two settings-the hospital and automated multiphasic screening. These examples underscore the importance of solving problems of measurement and valuation of a project or program in its concrete setting. Finally, barriers to the performance of sound and systematic analysis are listed, and the political context of decision making in the public sector is emphasized.

scholarly journals Pricing methods in outcome-based contracting: δ1: cost effectiveness analysis and cost-utility analysis-based pricing

2020 ◽  
Vol 23 (11) ◽  
pp. 1215-1222 ◽  
Author(s):  
Nimer S. Alkhatib ◽  
Kenneth Ramos ◽  
Brian Erstad ◽  
Marion Slack ◽  
Ali McBride ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Cost Utility ◽  
Cost Effectiveness Analysis ◽  
Cost Utility Analysis ◽  
Utility Analysis ◽  
Effectiveness Analysis

Health Economics of Vaccination and Immunization Practices

2021 ◽  
Author(s):  
Thomas Szucs
Keyword(s):  
Cost Effectiveness ◽  
Cost Benefit Analysis ◽  
Cost Savings ◽  
Cost Benefit ◽  
Quality Adjusted Life Year ◽  
Cost Utility ◽  
Cost Effectiveness Analysis ◽  
Vaccination Programs ◽  
Effectiveness Analysis ◽  
Wide Range

The economic importance of vaccines lies partly in the burden of disease that can be avoided and partly in the competition for resources between vaccines and other interventions. Decision-makers are increasingly demanding hard economic data as a basis for the allocation of limited healthcare resources. The main types of evaluation available are cost-benefit analysis (best use of allocated resources), cost-effectiveness analysis (a tool that helps policy-makers decide on the overall allocation of resources), and cost-utility analysis (quality-adjusted life year [QALY] which allows for a direct comparison of a wide range of medical interventions). The cost per QALY for a range of vaccinations can be compared in order to plan a vaccination program. Public health vaccines warrant a cost-benefit approach, in order to determine if they are worthwhile, whereas recommended vaccines might be more usefully assessed by cost-effectiveness analysis. Although cost-savings do not necessarily equate with cost-effectiveness, cost-savings are achieved in many vaccination programs.

Sign in / Sign up

Export Citation Format

Share Document